Simon Völkl

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Epstein Barr Virus

Positron Emission Tomography

Loop Mediated Isothermal Amplification

Top Venues

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nina Eisenhauer, Maurizio Miano, Nora Naumann-Bartsch, Jörg Leyh, Gianluca Dell'Orso, Michael Aigner, Gisela Fecker, Claas Hinze, Helmut Wittkowski, Heiko Bruns, Jakob Zierk, Markus Metzler, Peter D Arkwright, Frederik Graw, Andreas Mackensen, Simon Völkl
Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function. American journal of hematology 99 (5) (2024)
Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, Katja Petry, Andreas Bosio, Angelika von Döllen, Wolfgang Hartmann, Holger N Lode, Dennis Görlich, Andreas Mackensen, Melanie Jungblut, Axel Schambach, Hinrich Abken, Claudia Rossig
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Nina Eisenhauer, Maurizio Miano, Nora Naumann-Bartsch, Jörg Leyh, Gianluca Dell'Orso, Michael Aigner, Gisela Fecker, Claas Hinze, Helmut Wittkowski, Heiko Bruns, Jakob Zierk, Markus Metzler, Peter D Arkwright, Frederik Graw, Andreas Mackensen, Simon Völkl
Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function. American journal of hematology 99 (5) (2024)
Ali Behzad, Christoph Feldmann-Schulz, Bernd Lenz, Lucy Clarkson, Celine Ludwig, Katharina Luttenberger, Simon Völkl, Kornhuber Johannes, Christiane Mühle, Claudia von Zimmermann
TaKeTiNa Music Therapy for Outpatient Treatment of Depression: Study Protocol for a Randomized Clinical Trial. Journal of clinical medicine 13 (9) (2024)
Ali Behzad, Christoph Feldmann-Schulz, Bernd Lenz, Lucy Clarkson, Celine Ludwig, Katharina Luttenberger, Simon Völkl, Kornhuber Johannes, Christiane Mühle, Claudia von Zimmermann
TaKeTiNa Music Therapy for Outpatient Treatment of Depression: Study Protocol for a Randomized Clinical Trial. Journal of clinical medicine 13 (9) (2024)
Nina Eisenhauer, Maurizio Miano, Nora Naumann-Bartsch, Jörg Leyh, Gianluca Dell'Orso, Michael Aigner, Gisela Fecker, Claas Hinze, Helmut Wittkowski, Heiko Bruns, Jakob Zierk, Markus Metzler, Peter D Arkwright, Frederik Graw, Andreas Mackensen, Simon Völkl
Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function. American journal of hematology (2024)
Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, Katja Petry, Andreas Bosio, Angelika von Döllen, Wolfgang Hartmann, Holger N Lode, Dennis Görlich, Andreas Mackensen, Melanie Jungblut, Axel Schambach, Hinrich Abken, Claudia Rossig
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Nina Eisenhauer, Maurizio Miano, Nora Naumann-Bartsch, Jörg Leyh, Gianluca Dell'Orso, Michael Aigner, Gisela Fecker, Claas Hinze, Helmut Wittkowski, Heiko Bruns, Jakob Zierk, Markus Metzler, Peter D Arkwright, Frederik Graw, Andreas Mackensen, Simon Völkl
Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function. American journal of hematology 99 (5) (2024)
Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, Katja Petry, Andreas Bosio, Angelika von Döllen, Wolfgang Hartmann, Holger N Lode, Dennis Görlich, Andreas Mackensen, Melanie Jungblut, Axel Schambach, Hinrich Abken, Claudia Rossig
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Marion Subklewe, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla M Reid, Rawan G Faramand, Marco L Davila, Karnav Modi, Erin A Dean, Christina A Bachmeier, Michael von Bergwelt-Baildon, Frederick L Locke, Wolfgang Andreas Bethge, Lars Bullinger, Andreas Mackensen, Pere Barba, Michael D Jain, Marion Subklewe
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Science advances 9 (38) (2023)
Judit Rial Saborido, Simon Völkl, Michael Aigner, Andreas Mackensen, Dimitrios Mougiakakos
Role of CAR T Cell Metabolism for Therapeutic Efficacy. Cancers 14 (21) (2022)
Sarah Lemire, Oana-Maria Thoma, Lucas Kreiss, Simon Völkl, Oliver Friedrich, Markus F Neurath, Sebastian Schürmann, Maximilian J Waldner
Natural NADH and FAD Autofluorescence as Label-Free Biomarkers for Discriminating Subtypes and Functional States of Immune Cells. International journal of molecular sciences 23 (4) (2022)
Ramona Erber, Sareetha Kailayangiri, Hanna Huebner, Matthias Ruebner, Arndt Hartmann, Lothar Häberle, Julia Meyer, Simon Völkl, Andreas Mackensen, Laura Landgraf, Carol I Geppert, Rüdiger Schulz-Wendtland, Matthias W Beckmann, Peter Andreas Fasching, Nicole Farwick, Claudia Rossig, Paul Gass
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes. Cancers 13 (21) (2021)